The goal of my research program is to work with knowledge users to inform national and international decisions about optimal infectious disease control and prevention strategies in the context of limited resources, and to provide better modeling tools for policy decisions. My team and I develop state-of-the-art transmission-dynamic models, analyze large population-level datasets, and use epidemiology and health economics to estimate the effectiveness and cost-effectiveness of infectious disease control and prevention strategies at the population-level and within vulnerable or at-risk groups.
Marc Brisson was external contributor to the “WHO preferred product characteristics document for therapeutic HPV vaccines” published online. [ WHO ]
Marc Brisson and Mélanie Drolet , along with our colleague at the research center Souleymane Diabaté participated in the Workshop on Mathematical Modeling of Cervical Cancer Screening in Ivory Coast and Burkina Faso, held in Abidjan, June 10-13, 2024. The project is supported by “Doctors of the World – France”. Marc Brisson and Souleymane Diabaté participated in person, Mélanie Drolet, virtually.
Marc Brisson and Mélanie Drolet participated in the Gavi HPV Vaccine Programme Face-to-Face (F2F) Sub-team Meeting, held in Geneva, Switzerland, from June 11-13, 2024.
Marc Brisson participated in the Technical Meeting: Accelerating HPV-related Cancer Elimination and HPV Faster, held in Antwerp, Belgium, June 6-7, 2024, and organized by the HPV Prevention and Control Board. He made 2 presentations on June 7:
Marc Brisson was invited as faculty to the 24th Advanced Course of Vaccinology (ADVAC) that took place at Les Pensières, Annecy, France, from 6 to 17 May 2024. He presented a course on “The role of health economics (including modelling) as a tool in analyzing vaccine policy options.” [ Faculty 2024 ] [ Program ]